Abingdon Health (LON:ABDX) Hits New 12-Month High – Should You Buy?

Abingdon Health Plc (LON:ABDX)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as GBX 13 and last traded at GBX 12.30, with a volume of 611741 shares traded. The stock had previously closed at GBX 12.50.

Abingdon Health Stock Performance

The company has a 50-day moving average of GBX 8.62 and a 200-day moving average of GBX 7.27. The firm has a market capitalization of £30.88 million, a price-to-earnings ratio of -15.19 and a beta of 0.12. The company has a current ratio of 1.91, a quick ratio of 1.96 and a debt-to-equity ratio of 15.05.

Abingdon Health (LON:ABDX) last announced its quarterly earnings data on Tuesday, March 17th. The company reported GBX (0.43) earnings per share (EPS) for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

About Abingdon Health

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.